Deutsche Bank Ag\ Atossa Therapeutics, Inc. Transaction History

Deutsche Bank Ag\

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$0.85 - $1.28 $61,561 - $92,704	-72,425 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$1.11 - $1.74 $1,529 - $2,397	1,378 Added 1.94%	72,425 $90,000
Q4 2021 Feb 11, 2022	SELL	$1.6 - $3.27 $90,723 - $185,415	-56,702 Reduced 44.39%	71,047 $114,000
Q3 2021 Nov 04, 2021	BUY	$2.89 - $6.4 $168,472 - $373,088	58,295 Added 83.93%	127,749 $416,000
Q2 2021 Aug 11, 2021	BUY	$1.52 - $8.62 $105,570 - $598,693	69,454 New	69,454 $439,000
Q4 2020 Feb 16, 2021	SELL	$0.85 - $2.43 $3,751 - $10,726	-4,414 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$1.98 - $4.35 $8,739 - $19,200	4,414 New	4,414 $11,000
Q1 2020 May 14, 2020	SELL	$0.79 - $1.62 $5,051 - $10,358	-6,394 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$1.25 - $1.87 $7,992 - $11,956	6,394 New	6,394 $10,000
Q3 2019 Nov 14, 2019	SELL	$1.96 - $2.52 $588 - $756	-300 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$2.03 - $3.58 $594 - $1,048	293 Added 4185.71%	300 $0
Q3 2018 Nov 14, 2018	SELL	$1.47 - $2.78 $1,606 - $3,038	-1,093 Reduced 99.36%	7 $0
Q2 2018 Apr 21, 2020	SELL	$2.2 - $5.28 $15 - $36	-7 Reduced 0.63%	1,100 $2,000
Q2 2018 Aug 14, 2018	BUY	$2.2 - $5.28 $2,435 - $5,844	1,107 New	1,107 $2,000

26.5M

466K

91.8K

Ticker ATOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,624,000
Market Cap $135M
Description
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing A...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.